Editorial: The Golden Future in Medicinal Chemistry: Perspectives and Resources From Old and New Gold-Based Drug Candidates.

Massai, Lara; Grguric-Sipka, Sanja; Liu, Wukun; Bertrand, Benoît; Pratesi, Alessandro

Massai, Lara; Grguric-Sipka, Sanja; Liu, Wukun; Bertrand, Benoît; Pratesi, Alessandro.

Afiliação

Massai L; Laboratory of Metals in Medicine (MetMed), Department of Chemistry "U. Schiff", University of Florence, Florence, Italy.
Grguric-Sipka S; Faculty of Chemistry, University of Belgrade, Belgrade, Serbia.
Liu W; School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Bertrand B; Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire (IPCM), Paris, France.
Pratesi A; Department of Chemistry and Industrial Chemistry (DCCI), University of Pisa, Pisa, Italy.

Front Chem ; 9: 665244, 2021.

Article em En | MEDLINE | ID: mdl-33816443

Palavras-chave

anticancer compounds; anticancer immunity; dihydrofolate reductase; enzyme inhibition; gold complexes; mass spectrometry; mode-of-action; protein metalation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Chem Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Chem Ano de publicação: 2021 Tipo de documento: Article